$184 Million is the total value of DCF Advisers, LLC's 96 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 64.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| QQQ | New | INVESCO QQQ TRput | $24,541,495 | – | 68,500 | +100.0% | 13.37% | – |
| MU | Buy | MICRON TECHNOLOGY INC | $11,088,890 | +10.2% | 163,000 | +2.2% | 6.04% | +13.6% |
| XNCR | Buy | XENCOR INC | $4,962,945 | -7.6% | 246,300 | +14.6% | 2.70% | -4.7% |
| AMD | Buy | ADVANCED MICRO DEVICES INC | $4,184,774 | +20.5% | 40,700 | +33.4% | 2.28% | +24.3% |
| INCY | Buy | INCYTE CORP | $2,570,765 | +2.0% | 44,500 | +9.9% | 1.40% | +5.1% |
| BMY | New | BRISTOL-MYERS SQUIBB COcall | $2,472,504 | – | 42,600 | +100.0% | 1.35% | – |
| BABA | Buy | ALIBABA GROUP HLDG LTDcall | $2,168,500 | +550.4% | 25,000 | +525.0% | 1.18% | +571.0% |
| T | Buy | AT&T INC | $2,140,350 | +5.2% | 142,500 | +11.8% | 1.17% | +8.6% |
| JQC | Buy | NUVEEN CR STRATEGIES INCOME | $2,125,200 | +7.9% | 420,000 | +7.7% | 1.16% | +11.3% |
| IWM | Buy | ISHARES TRrussel 2000 etf | $2,032,510 | +228.9% | 11,500 | +248.5% | 1.11% | +239.6% |
| BABA | Buy | ALIBABA GROUP HLDG LTDsponsored ads | $1,847,562 | +24.9% | 21,300 | +20.0% | 1.01% | +28.6% |
| F | Buy | FORD MTR CO DEL | $1,242,000 | -3.4% | 100,000 | +17.6% | 0.68% | -0.3% |
| REGN | New | REGENERON PHARMACEUTICALSput | $1,152,144 | – | 1,400 | +100.0% | 0.63% | – |
| ORCL | Buy | ORACLE CORPput | $1,059,200 | +97.6% | 10,000 | +122.2% | 0.58% | +103.9% |
| OI | Buy | O-I GLASS INC | $991,253 | +32.8% | 59,250 | +69.3% | 0.54% | +37.1% |
| XBI | New | SPDR SER TRs&p biotech | $985,770 | – | 13,500 | +100.0% | 0.54% | – |
| QCOM | Buy | QUALCOM INC | $944,010 | +13.3% | 8,500 | +21.4% | 0.51% | +16.8% |
| LNDC | Buy | LIFECORE BIOMEDICAL INC | $911,089 | +7.7% | 120,754 | +38.0% | 0.50% | +11.0% |
| INTC | Buy | INTEL CORP | $835,425 | +42.8% | 23,500 | +34.3% | 0.46% | +47.2% |
| BUR | Buy | BURFORD CAP LTD | $826,000 | +44.3% | 59,000 | +25.5% | 0.45% | +49.0% |
| AMGN | New | AMGEN INCput | $806,280 | – | 3,000 | +100.0% | 0.44% | – |
| PYPL | Buy | PAYPAL HLDGS INC | $789,210 | +195.7% | 13,500 | +237.5% | 0.43% | +205.0% |
| New | EA SERIES TRUSTalpha arch 1-3 | $777,600 | – | 7,500 | +100.0% | 0.42% | – | |
| RTX | New | RTX CORPORATIONcall | $719,700 | – | 10,000 | +100.0% | 0.39% | – |
| MU | Buy | MICRON TECHNOLOGY INCcall | $612,270 | +14.1% | 9,000 | +5.9% | 0.33% | +18.0% |
| AAPL | New | APPLE INCput | $599,235 | – | 3,500 | +100.0% | 0.33% | – |
| QCOM | New | QUALCOM INCput | $555,300 | – | 5,000 | +100.0% | 0.30% | – |
| Buy | WOLFSPEED INC | $533,400 | +37.1% | 14,000 | +100.0% | 0.29% | +41.3% | |
| EVTCY | Buy | EVOTEC AGsponsored ads | $484,094 | +0.2% | 49,047 | +14.8% | 0.26% | +3.5% |
| TEVA | Buy | TEVA PHARMACEUTICAL INDS LTDsponsored ads | $453,900 | +54.6% | 44,500 | +14.1% | 0.25% | +59.4% |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $318,780 | +4.9% | 1,800 | +12.5% | 0.17% | +8.1% |
| MSFT | New | MICROSOFT CORPput | $315,750 | – | 1,000 | +100.0% | 0.17% | – |
| AMD | New | ADVANCED MICRO DEVICES INCcall | $308,460 | – | 3,000 | +100.0% | 0.17% | – |
| BMY | New | BRISTOL-MYERS SQUIBB CO | $304,710 | – | 5,250 | +100.0% | 0.17% | – |
| RVNC | New | REVANCE THERAPEUTICS INC | $303,955 | – | 26,500 | +100.0% | 0.17% | – |
| INTC | New | INTEL CORPcall | $266,625 | – | 7,500 | +100.0% | 0.14% | – |
| BMY | New | BRISTOL-MYERS SQUIBB COput | $232,160 | – | 4,000 | +100.0% | 0.13% | – |
| IMGN | Buy | IMMUNOGEN INC | $203,930 | +4.4% | 12,850 | +24.2% | 0.11% | +7.8% |
| New | WOLFSPEED INCput | $152,400 | – | 4,000 | +100.0% | 0.08% | – | |
| LCTX | Buy | LINEAGE CELL THERAPEUTICS IN | $97,646 | +361.7% | 82,751 | +451.7% | 0.05% | +381.8% |
| KIRK | Buy | KIRKLANDS INC | $60,604 | -20.2% | 35,235 | +29.4% | 0.03% | -17.5% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| INTRA-CELLULAR THERAPIES INC | 16 | Q3 2023 | 10.2% |
| MICRON TECHNOLOGY INC | 16 | Q3 2023 | 6.7% |
| ALPHABET INC | 16 | Q3 2023 | 5.8% |
| ABBVIE INC | 16 | Q3 2023 | 7.9% |
| REGENERON PHARMACEUTICALS | 16 | Q3 2023 | 5.5% |
| ARGENX SE | 16 | Q3 2023 | 6.4% |
| SPDR GOLD TRUST | 16 | Q3 2023 | 6.6% |
| XENCOR INC | 16 | Q3 2023 | 4.1% |
| BK OF AMERICA CORP | 16 | Q3 2023 | 5.4% |
| ORACLE CORP | 16 | Q3 2023 | 3.2% |
View DCF Advisers, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-11 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-10 |
| 13F-HR | 2021-11-15 |
View DCF Advisers, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.